Immunogen (IMGN) Misses Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
Financial Fact:
Research and development support: 1.35M
Today's EPS Names:
INLB, FTXP, EDXC, More
Financial Fact:
Research and development support: 1.35M
Today's EPS Names:
INLB, FTXP, EDXC, More
Join SI Premium – FREE
Immunogen (NASDAQ: IMGN) reported Q2 EPS of ($0.24), $0.03 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $14.2 million versus the consensus estimate of $16.18 million.
GUIDANCE:
Immunogen sees FY2022 revenue of $75-85 million, versus the consensus of $84.7 million.
For earnings history and earnings-related data on Immunogen (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- GSX Techedu Inc. (GOTU) Misses Q2 EPS by 11c; offers guidance
- PagerDuty, Inc. (PD) Tops Q2 EPS by 1c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
